Asia Vaccines Market Forecast to 2029

Thursday, December 5, 2019 Drug News
Email Print This Page Comment bookmark
Font : A-A+

NEW YORK, Dec. 5, 2019 /PRNewswire/ --

Conjugate Vaccines, Inactivated and Subunit Vaccines, Live Attenuated Vaccines, Recombinant Vaccines, Toxoid Vaccines, Influenza, Hepatitis, Polio, Meningococcal, DTP, Rotavirus, MMR, HPV

Read the full report:

SUBMARKET: Regional Markets Asia vaccines market is estimated at $7bn in 2018 and is expected to grow at a CAGR of 8.8% during the first half of the forecast period. The Japanese vaccines market held 30% share of the Asian vaccines market in 2018.  How this report will benefit you Read on to discover how you can exploit the future business opportunities emerging in this sector. In this brand new 178-page report you will receive 82 charts"€" all unavailable elsewhere. The 178-page report provides clear detailed insight into the Asian vaccines market. Discover the key drivers and challenges affecting the market. By ordering and reading our brand-new report today you stay better informed and ready to act. Report Scope - Asia Vaccines Market revenue forecasts to 2029 - Asia Vaccines Market revenue forecasts to 2029 by Vaccine Technology: - Conjugate Vaccines - Inactivated and Subunit Vaccines - Live Attenuated Vaccines - Recombinant Vaccines - Toxoid Vaccines - Asia Vaccines Market revenue forecasts to 2029 by Indication: - Influenza - Hepatitis - Polio - Meningococcal - DTP - Rotavirus - MMR - HPV - Others Asia Vaccines Market Forecast to 2029 - Asia Vaccines Market revenue forecasts to 2029 by Country: - Japan - China - India - Australia - South Korea - Vietnam - Philippines - Thailand - Indonesia - Rest of Asia Further segmented by indication and vaccine technology. - Profiles of the selected leading companies: - Astellas - AstraZeneca - CSL, Ltd. - Emergent BioSolutions, Inc. - GlaxoSmithKline - Johnson & Johnson - Merck - Mitsubishi Tanabe Pharma Corporation - Pfizer - Sanofi - Serum Institute of India Pvt. Ltd. - Sun Pharmaceuticals Industries, Ltd. - Takeda - This report provides a Pipeline Analysis - This report discusses factors that drive and restrain the market. This report also discusses trends and opportunities in the market. - Key Questions Answered by this Report: - What is the current size of Asia vaccines market? How much will this market be worth from 2018 to 2029? - What are the main drivers and restraints that will shape Asia vaccines market over the next ten years? - What are the main segments within Asia vaccines market? How much will each of these segments be worth for the period 2018 to 2029? How will the composition of the market change during that time, and why? - What factors will affect that industry and market over the next ten years? - What are the largest national markets for the Asian vaccines market? What is their current status and how will they develop over the next ten years? What are their revenue potentials to 2029? - Who are the leading companies and what are their activities, results, developments and prospects?Read the full report: About Reportlinker ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place. __________________________ Contact Clare: US: (339)-368-6001 Intl: +1 339-368-6001

Cision View original content:

SOURCE Reportlinker

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions
Premium Membership Benefits

News A - Z



Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store